A Glimpse Into The Expert Outlook On Rapid7 Through 15 Analysts
Ratings for Rapid7 (NASDAQ:RPD) were provided by 15 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 0 | 11 | 2 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 0 | 4 | 1 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 6 | 1 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $17.93, a high estimate of $27.00, and a low estimate of $13.00. Experiencing a 19.23% decline, the current average is now lower than the previous average price target of $22.20.
Breaking Down Analyst Ratings: A Detailed Examination
A clear picture of Rapid7's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Joseph Gallo | Jefferies | Lowers | Hold | $13.00 | $18.00 |
| Gregg Moskowitz | Mizuho | Lowers | Neutral | $16.00 | $20.00 |
| Roger Boyd | UBS | Lowers | Buy | $25.00 | $29.00 |
| Fatima Boolani | Citigroup | Lowers | Neutral | $15.00 | $25.00 |
| Rob Owens | Piper Sandler | Lowers | Neutral | $16.00 | $19.00 |
| Matthew Hedberg | RBC Capital | Lowers | Sector Perform | $16.00 | $19.00 |
| Saket Kalia | Barclays | Lowers | Underweight | $15.00 | $18.00 |
| Patrick Colville | Scotiabank | Lowers | Sector Perform | $18.00 | $20.00 |
| Rudy Kessinger | DA Davidson | Lowers | Underperform | $14.00 | $16.00 |
| Brian Essex | JP Morgan | Lowers | Neutral | $20.00 | $22.00 |
| T. Michael Walkley | Canaccord Genuity | Lowers | Buy | $27.00 | $32.00 |
| Saket Kalia | Barclays | Lowers | Equal-Weight | $18.00 | $21.00 |
| Junaid Siddiqui | Truist Securities | Lowers | Hold | $18.00 | $22.00 |
| Rob Owens | Piper Sandler | Lowers | Neutral | $19.00 | $30.00 |
| Joseph Gallo | Jefferies | Lowers | Hold | $19.00 | $22.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Rapid7. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Rapid7 compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Rapid7's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into Rapid7's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Rapid7 analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Unveiling the Story Behind Rapid7
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
Financial Milestones: Rapid7's Journey
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Rapid7's revenue growth over a period of 3M has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 1.54%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Rapid7's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 4.5%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 9.01%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Rapid7's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.59%, the company showcases efficient use of assets and strong financial health.
Debt Management: Rapid7's debt-to-equity ratio stands notably higher than the industry average, reaching 7.63. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
The Significance of Analyst Ratings Explained
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.